Reach Us +44-1522-440391
Editor - Sameera Peraramelli | Stanford University School of Med | 25920
ISSN: 2165-7831

Journal of Blood & Lymph
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Relevant Topics

Sameera Peraramelli

Sameera Peraramelli
Editor Sameera Peraramelli Department of Hematology Stanford School of Medicine USA
Stanford University School of Medicine


Dr. Sameera Peraramelli earned her PhD in Biochemistry with a focus on blood coagulation inhibitors at Maastricht University, the Netherlands in 2015. She joined Department of Hematology, Stanford school of medicine as a hematology and cancer biology postdoctoral scholar in 2016. She is interested in understanding the role of thrombin cleaved osteopontin in growth and progression of cancer. Dr. Peraramelli has received young investigator award at International Society of Thrombosis and Hemostasis (ISTH) 2017 for this work.

Research Interest

Her long-term research interests involve the development of a comprehensive understanding of the interactions between blood coagulation abnormalities in cancer patients. Her plan is to lead the research to study the inter-link between blood coagulation and cancer biology (malignant and non-malignant hematology). Cancer patients have coagulation abnormalities, these abnormalities in turn aid the tumor progression. She worked on blood coagulation factors during my PhD and attained comprehensive insight into the mechanism involved in careful regulation of coagulation factors. She acquired knowledge of molecular biology, biochemistry and enzymatic kinetics by handling multiple projects during her PhD dissertation. Now for her postdoctoral research, she is working with mouse melanoma model to understand the role of osteopontin and its cleavage products in tumor development. Specifically she is interested in studying three primary topics. 1) Development of bifunctional therapeutic approaches targeting the malignant tumors and resolving the coagulation abnormalities; 2) Investigating the biomarkers for cancer patients with higher risk of developing the coagulation disorders hence preventing the thrombohemorragic events; 3) Novel therapies to manage cancer patients with thrombosis and hemorrhages.


Editor Note-Journal of Blood and Lymph

Sameera Peraramelli
Editor Note: J Blood Lymph 2018, 8: e125
DOI: 10.4172/2165-7831.1000e125
Leave Your Message 24x7